Revised international prognostic index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-Cell lymphoma (DLBCL) treated with rituximab and CHOP (R-CHOP).

被引：0
|
作者：
Sehn, LH
Chhanabhai, M
Fitzgerald, C
Gill, K
Hoskins, P
Klasa, R
Savage, K
Shenkier, T
Sutherland, J
Wilson, K
Gascoyne, RD
Connors, JM
机构：
[1] British Columbia Canc Agcy, Div Med Oncol, Vancouver, BC V5Z 4E6, Canada
[2] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
[3] British Columbia Canc Agcy, Div Pathol, Vancouver, BC V5Z 4E6, Canada
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
492
引用
收藏
页码：147A / 147A
页数：1
相关论文
共 50 条
  • [41] MicroRNAs Are Independent Predictors of Outcome in Diffuse Large B-Cell Lymphoma Patients Treated with R-CHOP
    Alencar, Alvaro J.
    Malumbres, Raquel
    Kozloski, Goldi A.
    Advani, Ranjana
    Talreja, Neha
    Chinichian, Shideh
    Briones, Javier
    Natkunam, Yasodha
    Sehn, Laurie H.
    Gascoyne, Randy D.
    Tibshirani, Rob
    Lossos, Izidore S.
    CLINICAL CANCER RESEARCH, 2011, 17 (12) : 4125 - 4135
  • [42] CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP
    Schmitz, Norbert
    Zeynalova, Samira
    Nickelsen, Maike
    Kansara, Roopesh
    Villa, Diego
    Sehn, Laurie H.
    Glass, Bertram
    Scott, David W.
    Gascoyne, Randy D.
    Connors, Joseph M.
    Ziepert, Marita
    Pfreundschuh, Michael
    Loeffler, Markus
    Savage, Kerry J.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (26) : 3150 - +
  • [43] Standard R-CHOP Therapy in Follicular Lymphoma and Diffuse Large B-Cell Lymphoma
    Tomita, Naoto
    Takasaki, Hirotaka
    Fujisawa, Shin
    Miyashita, Kazuho
    Ogusa, Eriko
    Kishimoto, Kumiko
    Matsuura, Shiro
    Sakai, Rika
    Koharazawa, Hideyuki
    Yamamoto, Wataru
    Fujimaki, Katsumichi
    Fujita, Hiroyuki
    Ishii, Yoshimi
    Taguchi, Jun
    Kuwabara, Hideyuki
    Motomura, Shigeki
    Ishigatsubo, Yoshiaki
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2013, 53 (02) : 121 - 125
  • [44] Standard R-CHOP Therapy in Follicular Lymphoma and Diffuse Large B-Cell Lymphoma
    Tomita, Naoto
    Takasaki, Hirotaka
    Fujisawa, Shin
    Miyashita, Kazuho
    Ogusa, Eriko
    Kishimoto, Kumiko
    Matsuura, Shiro
    Sakai, Rika
    Koharazawa, Hideyuki
    Yamamoto, Wataru
    Fujimaki, Katsumichi
    Fujita, Hiroyuki
    Yamamoto, Yoshimi
    Taguchi, Jun
    Kuwabara, Hideyuki
    Motomura, Shigeki
    Ishigatsubo, Yoshiaki
    BLOOD, 2011, 118 (21) : 708 - 709
  • [45] Enhancement of the International Prognostic Index with hematologic parameters: A new prognostic model for diffuse large B-cell lymphoma treated with R-CHOP
    Chen, H.
    Zhong, Q.
    Qin, Y.
    Yang, J.
    Liu, P.
    He, X.
    Zhou, S.
    Zhang, C.
    Gui, L.
    Yang, S.
    Zhou, L.
    Shi, Y.
    ANNALS OF ONCOLOGY, 2021, 32 : S776 - S777
  • [46] Prognostic significance of BLK expression in R-CHOP treated diffuse large B-cell lymphoma
    Choi, Soyeon
    Lee, Yoo Jin
    Choi, Yunsuk
    Kim, Misung
    Kim, Hyun-Jung
    Kim, Ji Eun
    Oh, Sukjoong
    Chae, Seoung Wan
    Cha, Hee Jeong
    Jo, Jae-Cheol
    JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE, 2022, 56 (05) : 281 - 288
  • [47] Prognostic Impact of Tumor Microenvironment on Diffuse Large B-Cell Lymphoma Treated with R-CHOP
    Gomez-Gelvez, J. C.
    Salama, M.
    Cogan, C.
    Leavitt, M.
    Inamdar, K.
    LABORATORY INVESTIGATION, 2013, 93 : 329A - 329A
  • [48] Prognostic Impact of Tumor Microenvironment on Diffuse Large B-Cell Lymphoma Treated with R-CHOP
    Gomez-Gelvez, J. C.
    Salama, M.
    Cogan, C.
    Leavitt, M.
    Inamdar, K.
    MODERN PATHOLOGY, 2013, 26 : 329A - 329A
  • [49] Diffuse large B-cell lymphoma: R-CHOP forever?
    Jedrzejczak, Wieslaw W.
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2015, 125 (10): : 713 - 714
  • [50] SERUM B2-MICROGLOBULIN LEVELS IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): PROGNOSTIC SIGNIFICANCE UNDER TREATMENT WITH RITUXIMAB-CHOP (R-CHOP)
    Vassilakopoulos, T. P.
    Anastasopoulou, A.
    Constantinou, N.
    Angelopoulou, M. K.
    Stavroulaki, E.
    Kalpadakis, C.
    Sachanas, S.
    Pappis, V.
    Tsirkinidis, P.
    Moschoyiannis, M.
    Tsopra, O.
    Tzenou, T.
    Gassiamis, A.
    Yiakoumis, X.
    Kyrtsonis, M. C.
    Kokoris, S. I.
    Siakantaris, M. P.
    Dimou, M.
    Georgiou, G.
    Plata, E.
    Viniou, N. A.
    Variamis, E.
    Konstantopoulos, K.
    Panayiotidis, P.
    Papadaki, H.
    Pangalis, G. A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 393 - 394
12345